Wedbush Lifts Earnings Estimates for Fennec Pharmaceuticals
Fennec Pharmaceuticals Inc. (TSE:FRX – Free Report) – Research analysts at Wedbush boosted their Q2 2025 earnings estimates for Fennec Pharmaceuticals in a research report issued to clients and investors on Tuesday, May 13th. Wedbush analyst D. Nierengarten now anticipates that the biopharmaceutical company will post earnings per share of ($0.07) for the quarter, up […]
Fennec Pharmaceuticals Inc. (TSE:FRX – Free Report) – Research analysts at Wedbush boosted their Q2 2025 earnings estimates for Fennec Pharmaceuticals in a research report issued to clients and investors on Tuesday, May 13th. Wedbush analyst D. Nierengarten now anticipates that the biopharmaceutical company will post earnings per share of ($0.07) for the quarter, up […]
